State Street Corp Legend Biotech Corp Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, State Street Corp holds 1,140,222 shares of LEGN stock, worth $42.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,140,222
Previous 1,135,487
0.42%
Holding current value
$42.7 Million
Previous $50.3 Million
10.49%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$418 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$281 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$248 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$214 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$189 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.27B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...